A patent update on therapeutic applications of urease inhibitors (2012–2018)
- 4 March 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 29 (3) , 181-189
Abstract
Introduction: Urease is a nickel containing metallo-enzyme that is commonly found in different bacteria, plants, algae and fungi, and mediates the growth of many pathogenic bacteria in the acidic environment of the stomach. Despite the large number of molecules known to have excellent urease inhibitory activity, there is an alarming lack of urease inhibitor drugs on the market. Area covered: This review aims to provide a comprehensive overview of the different types of molecules patented as potent urease inhibitors from the year 2012 to 2018. Expert opinion: Urease is an important target to treat urease related bacterial infections manifesting as gastric ulcers, urinary tract infections, and kidney stones. Although a large number of different molecules as inhibitors of urease have been reported, only a few have advanced to clinical trials. The development of new effective urease inhibitors demands new suitable lead molecules. This review covers the patents on urease inhibitors in recent years (2012-2018) with a hope to bring into focus the issue and need for availability of new urease inhibitors on the market.Keywords
Funding Information
- Higher Education Commission (4732/5743)
This publication has 43 references indexed in Scilit:
- Chemistry of Ni2+ in Urease: Sensing, Trafficking, and CatalysisAccounts of Chemical Research, 2011
- Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent reviewExpert Opinion on Therapeutic Patents, 2011
- Synthesis, Crystal Structures, and Urease Inhibitory Activities of Three Novel Thiocyanato‐bridged Polynuclear Schiff Base Cadmium(II) ComplexesZeitschrift für anorganische und allgemeine Chemie, 2007
- Mechanisms of inhibition by fluoride of urease activities of cell suspensions and biofilms of Staphylococcus epidermidis, Streptococcus salivarius, Actinomyces naeslundii and of dental plaqueOral Microbiology and Immunology, 2005
- Three-Dimensional Quantitative Structure-Activity Relationship and Comparative Molecular Field Analysis of Dipeptide Hydroxamic Acid Helicobacter pylori Urease InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- 70 Years of Crystalline Urease: What Have We Learned?Accounts of Chemical Research, 1997
- X‐ray Absorption Spectroscopy Study of Native and Phenylphosphorodiamidate‐Inhibited Bacillus pasteurii UreaseEuropean Journal of Biochemistry, 1996
- Bacterial ureases: structure, regulation of expression and role in pathogenesisMolecular Microbiology, 1993
- Urease inhibitors for hepatic coma: Inhibition of 14C-urea hydrolysis in mice by alkyl hydroxamatesBiochemical Medicine, 1967
- Specific inhibition of urease by hydroxamic acidsBiochimica et Biophysica Acta, 1962